Physician profile
Kyle Simonsen
NPI 1851850960
$3,097.51
in general payments reported to CMS, 2019-2025
8 companies · $2,996 in 2025
The $2,996 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.32 · 2024: $63.66 · 2025: $2,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,527 · Food and Beverage: $1,304 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,526.61 |
| Food and Beverage | $1,303.58 |
| Education | $229.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,413.88 | 2025 | Inspiris Resilia Aortic Valve, Konect Resilia, Mitris Resilia Mitral Valve |
| Pulmonx Corporation | $338.11 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Mid-Atlantic Surgical Systems, LLC | $145.93 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $97.61 | 2025 | |
| Integra Lifesciences Corporation | $38.32 | 2022 | |
| Abiomed | $23.21 | 2024 | Impella |
| Atricure, INC. | $21.00 | 2024 | |
| Ethicon US, LLC | $19.45 | 2024 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Simonsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.